• Nutex Health swung to profit in Q2, with net income attributable to shareholders of USD 65.84 million versus a loss a year earlier.
• Operating income rose to USD 121.72 million, while revenue fell 13.62% to USD 210.75 million.
• Adjusted EBITDA (non-GAAP) increased 25.65% to USD 89.99 million.
• Patient visits climbed 9.6% to 49,962, while hospital division revenue dropped 14.6% to USD 201.85 million.
• Arbitration-related costs totaled USD -12.5 million, reflecting a USD 52.3 million reduction to contract services expense tied to HaloMD and fee changes.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nutex Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-054268), on August 06, 2026, and is solely responsible for the information contained therein.